Home / Inspections / 1242651

FDA Inspection 1242651 — Carter BloodCare at Keller

Carter BloodCare at Keller — FEI 3003706080

The FDA completed an inspection of Carter BloodCare at Keller on June 26, 2024 in Keller, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 26, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Keller, TX (United States)

Facility

Other inspections at this facility

  • 1079838 (NAI Thu Jan 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1015107 (NAI Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910813 (NAI Wed Jan 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 835678 (NAI Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 721800 (NAI Wed Apr 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources